Medical Advisor- Ideation

Dr. Reddy’s Laboratories Ltd.; Mumbai; On-site; INR 2,800,000 - 4,200,000; Full time

Job summary

Dr. Reddy’s Laboratories Ltd. seeks a Medical Advisor – Ideation & Portfolio Development to provide scientific leadership for identifying and differentiating new product opportunities across therapeutic areas.

You will collaborate with Portfolio, R&D, Clinical Development, Regulatory and other cross-functional teams to evaluate pipelines through literature, evidence, guidelines and databases. The role covers end-to-end product journey from ideation to launch readiness, with medical

Qualifications

• MBBS with MD Pharmacology/Medicine required.
• 2–5 years in Medical Affairs or related roles preferred.
• Experience in scientific evaluation of pipeline assets is an advantage.

Responsibilities

• Lead medical evaluation of pipeline opportunities in collaboration with Portfolio team.
• Develop medical recommendations and rationale for Go/No-Go decisions.
• Provide medical inputs for regulatory strategy and development plans.
• Translate complex evidence into clear strategic recommendations for portfolio decisions.

Skills

Scientific evaluation

Clinical interpretation

Regulatory understanding

Cross-functional collaboration

Portfolio evaluation

Education

MBBS with MD Pharmacology

Job description

Company Description

Dr. Reddy’s Laboratories Ltd. is a leading multinational pharmaceutical company based across global locations. Each of our 24,000 plus employees comes to work every day for one collective purpose: to accelerate access to affordable and innovative medicines because Good Health Can’t Wait.

We started in 1984 with a modest investment, 20 employees and a bold vision. Today, we have research and development centres, manufacturing facilities or a commercial presence in 66 countries.

For nearly four decades, we have stood for access, affordability and innovation based on the bedrock of deep science, progressive people practices and robust corporate governance. As the pharmaceutical industry evolves and undergoes disruption, we see an opportunity – to strengthen our core further (the next steps) and to build the future (the new bets).

‘The Next and the New’ is how we aim to continue to be the partner of choice – purpose-driven, future-ready and sustainable. Our aim is to reach over 1.5 Bn+ patients across the world by 2030 by growing our core businesses and building for the future with sustainability at the core of our purpose and strategy. Sustainability for us means operating in a manner that respects people, planet and purpose – helping us conserve precious resources, serve our patients, create value for stakeholders, give back to society, fulfil our potential and maintain our integrity and transparency

Dr Reddy’s maintains a work environment, free from discrimination and is an equal opportunity employer. We are committed to employ & nurture all qualified diverse workforce without regard to race, colour religion, nationality, sex, age, disability status, genetics, sexual orientation, gender expression, citizenship or any other characteristic or classification protected by applicable law(s) of the country we operate in. We treasure every talent, and recognize merit and diversity in our organization.

Job Description

Job Description

Job Summary

The Medical Advisor – Ideation & Portfolio Development will provide scientific and clinical leadership for the identification, evaluation, differentiation and development of new product opportunities across therapeutic areas.

The role will work closely with Portfolio, R&D, Clinical Development, Regulatory and other cross-functional teamsto evaluate pipeline opportunities through comprehensive assessment of scientific literature, clinical evidence, treatment guidelines, competitive intelligence, global development pipelines and relevant medical/scientific databases.

The Medical Advisor will contribute across the end-to-end product journey—from ideation and opportunity evaluation through product selection, development, regulatory approval and readiness for launch, following which the product is transitioned to the respective Medical Affairs/Commercial teams.

Roles & Responsibilities

Pipeline Scouting & Ideation

• Continuously evaluate the global pharmaceutical and clinical development landscapeto identify potential new product, molecule, indication, formulation and combination opportunities.
• Conduct structured searches across scientific literature, clinical trial registries, regulatory databases, treatment guidelines, competitive intelligence platforms and other relevant databases.
• Identify emerging mechanisms of action, evolving standards of care, unmet medical needs and therapeutic areas with potential relevance to the India portfolio.
• Generate scientifically differentiated product concepts based on clinical need, emerging evidence and competitive landscape.

Medical & Scientific Evaluation of Opportunities

• Lead comprehensive medical evaluation of pipeline opportunitiesin collaboration with the Portfolio team.
• Assess opportunities based on:
  • Unmet medical need and current standard of care
  • Target patient population and patient journey
  • Mechanism of action and biological rationale
  • Clinical efficacy and safety
  • Comparative clinical positioning
  • Global and Indian treatment guidelines
  • Development stage and probability of clinical success
  • Competitive and future treatment landscape
  • Potential differentiation in the Indian market
• Develop clear medical recommendations and scientific rationale for Go/No-Go product selection decisions.
• Present medical evaluations and recommendations to cross-functional teams and relevant governance/decision-making forums.

Portfolio Partnership

• Work closely with the Portfolio/Business Development teamsto scientifically assess internal and external product opportunities.
• Provide the medical perspective for prioritisation and selection of differentiated portfolio opportunities.
• Support assessment of molecules, combinations, formulations, indications and lifecycle opportunities proposed for portfolio inclusion.
• Translate complex scientific and clinical evidence into clear strategic recommendations for portfolio decision-making.

Product Differentiation & R&D Collaboration

• Partner closely with R&D/Formulation Development teamsto identify opportunities for meaningful product differentiation.
• Provide medical input into the development of:
  • Novel formulations
  • Fixed-dose combinations
  • Dose/strength optimisation
  • Drug-delivery approaches
  • New indications
  • Patient-centric product features
• Define the clinical and medical rationale for differentiationversus currently available standards of care and anticipated future competitors.
• Ensure proposed differentiation addresses a meaningful physician, patient or healthcare-system need rather than being purely formulation-driven.

Drug Development Support

• Provide medical and scientific inputs throughout the drug/product development process.
• Contribute to development strategy, target product profile and clinical development considerations wherever required.
• Provide inputs into study concepts, endpoints, patient populations, comparators and other clinically relevant aspects of development.
• Review and interpret emerging clinical data and assess its implications for the evolving product strategy.
• Collaborate with Clinical Development, R&D and Regulatory teams to address scientific or clinical questions arising during development.

Regulatory & Approval Support

• Provide medical inputs for regulatory strategy and submissions for new products/indications.
• Support scientific responses to regulatory queries and participate in regulatory/subject expert discussions wherever required.
• Ensure that the scientific positioning of the product remains aligned with available evidence and the proposed clinical use throughout the approval process.

Product Transition & Launch Handover

• Develop a clear medical product narrativecovering unmet need, target patient, clinical value proposition, differentiation and appropriate positioning.
• Support medical readiness during the pre-launch phase.
• Once the product reaches the appropriate stage of approval/launch readiness, ensure structured handover of scientific strategy, evidence and product positioning to the respective Medical Affairs and launch teams.
• Provide scientific support during transition to ensure continuity from the original product concept to its intended clinical positioning.

Key Cross-Functional Interfaces

The role will work extensively with:

Portfolio / Business Development | R&D / Formulation Development | Clinical Development | Regulatory Affairs | Intellectual Property | Medical Affairs | Commercial/Marketing | Project Management and Senior Leadership

Key Skills & Attributes

• Strong scientific and clinical evaluation capabilities
• Ability to critically interpret clinical trials and medical literature
• Understanding of drug development and regulatory pathways
• Strong understanding of treatment guidelines and evolving standards of care
• Ability to assess unmet need, clinical differentiation and future competitive landscapes
• Strong analytical and strategic thinking
• Ability to integrate information from multiple scientific databases and sources into actionable recommendations
• Ability to translate science into portfolio and product-development decisions
• Intellectual curiosity and strong external/pipeline orientation
• Effective cross-functional collaboration in a matrix environment
• Strong written, presentation and stakeholder-management skills
• Ability to manage multiple therapeutic areas and product evaluations simultaneously

Educational Qualification

MBBS with M.D. Pharmacology/Medicine or full-time postgraduate qualification in an appropriate medical discipline.

Preferred Experience

2–5 years of relevant pharmaceutical industry experience in Medical Affairs, Portfolio Evaluation, Clinical Development, R&D interface, New Product Planning or related roles.

Experience in scientific evaluation of pipeline assets, new product ideation, product differentiation or cross-functional drug development would be an advantage.